Clinical effect of silymarin combined with levocarnitine on non-alcoholic fatty liver disease

Objective:To assess the therapeutic effect of silymarin combined with levocarnitine on non-alcoholic fatty liver disease(NAFL). Methods:Sixty-eight patients with NAFL were randomly assigned 34 cases to receive silymarin combined with levocarnitine(8 weeks) as treatment group. Control group 34 cases were treated with silymarin(8 weeks). Before and after treatment serum transaminase levels,triglyceride,cholesterol and liver ultrasonography were detected pre-and porstreatment. Results:The total effective rate was 91.1% in treatment group,significantly higher than control group after treat ment(P0.05). Conclusion:Silymarin combined with levocarnitine have a significant therapeutic effect on the treatment of NAFL.